Find Omadacycline manufacturers, exporters & distributors on PharmaCompass

Omadacycline

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

9 API Suppliers, 4 NDC API, 9 Listed Suppliers, $ API Reference Price

9 API Suppliers
4 NDC API
9 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

22 Drugs in Development

22 Drugs in Development

FINISHED DOSAGE FORMULATIONS

2 FDF Dossiers, 2 FDA Orange Book

2 FDF Dossiers
2 FDA Orange Book

DIGITAL CONTENT

55 NEWS #PharmaBuzz

media
55 NEWS #PharmaBuzz

MARKET PLACE

10 APIs

marketPlace
10 APIs

PATENTS & EXCLUSIVITIES

15 US Patents, 4 US Exclusivities

patents
15 US Patents
4 US Exclusivities

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Amadacycline, 389139-89-3, Nuzyra, Ptk 0796, Omadacycline [usan], Ptk-0796

Molecular Formula

C₂₉H₄₀N₄O₇

Molecular Weight

556.6 g/mol

InChI Key

VJYKVCURWJGLPG-IQZGDKDPSA-N

FDA UNII

090IP5RV8F

Omadacycline has been used in trials studying the treatment of Bacterial Pneumonia, Bacterial Infections, Community-Acquired Infections, and Skin Structures and Soft Tissue Infections. Omadacycline represents a significant advance over the well-known tetracycline family, and has been shown to be highly effective in animal models at treating increasingly problematic, clinically prevalent infections caused by gram-positive bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA), and by gram-negative, atypical and anaerobic bacteria, including those resistant to currently available classes of antibiotics and known to cause diseases such as pneumonias, urinary tract infections, skin diseases and blood-borne infections in both the hospital and community settings.

Omadacycline is a Tetracycline-class Antibacterial.

1 2D Structure

Omadacycline

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-9-[(2,2-dimethylpropylamino)methyl]-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide

2.1.2 InChI

InChI=1S/C29H40N4O7/c1-28(2,3)12-31-11-14-10-17(32(4)5)15-8-13-9-16-21(33(6)7)24(36)20(27(30)39)26(38)29(16,40)25(37)18(13)23(35)19(15)22(14)34/h10,13,16,21,31,34-35,38,40H,8-9,11-12H2,1-7H3,(H2,30,39)/t13-,16-,21-,29-/m0/s1

2.1.3 InChI Key

VJYKVCURWJGLPG-IQZGDKDPSA-N

2.1.4 Canonical SMILES

CC(C)(C)CNCC1=CC(=C2CC3CC4C(C(=O)C(=C(C4(C(=O)C3=C(C2=C1O)O)O)O)C(=O)N)N(C)C)N(C)C

2.1.5 Isomeric SMILES

CC(C)(C)CNCC1=CC(=C2C[C@H]3C[C@H]4[C@@H](C(=O)C(=C([C@]4(C(=O)C3=C(C2=C1O)O)O)O)C(=O)N)N(C)C)N(C)C

2.2 Other Identifiers

2.2.1 UNII

090IP5RV8F

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Nuzyra

2.3.2 Depositor-Supplied Synonyms

1. Amadacycline

2. 389139-89-3

3. Nuzyra

4. Ptk 0796

5. Omadacycline [usan]

6. Ptk-0796

7. Bay 73-6944

8. 090ip5rv8f

9. 389139-89-3 (free Base)

10. (4s,4as,5ar,12ar)-4,7-bis(dimethylamino)-9-[(2,2-dimethylpropylamino)methyl]-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide

11. Omadacycline (usan)

12. (4s,4as,5ar,12as)-4,7-bis(dimethylamino)-9-(((2,2-dimethylpropyl)amino)methyl)- 3,10,12,12a- Tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2- Carboxamide

13. Amadacycline Methanesulfonate

14. Omadacycline [usan:inn]

15. Unii-090ip5rv8f

16. (4s,4as,5ar,12as)-4,7-bis(dimethylamino)-9-[(2,2-dimethylpropylamino)methyl]-3,10,12,12a-tetrahydroxy-1,11-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide

17. 2-naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-(((2,2-dimethylpropyl)amino)methyl)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4s,4as,5ar,12as)-

18. 2-naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-[[(2,2-dimethylpropyl)amino]methyl]-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4s,4as,5ar,12as)-

19. Mk-2764

20. Omadacycline [mi]

21. Omadacycline [inn]

22. Omadacycline [who-dd]

23. Schembl1525961

24. 9-neopentylaminomethylminocycline

25. Chembl1689772

26. Schembl17150976

27. Schembl20952297

28. Gtpl10839

29. Ptk-796

30. Ptk0796

31. Chebi:177758

32. Dtxsid201027687

33. Bcp12946

34. Ex-a4252

35. Zinc4836283

36. Compound 6 [pmid: 21302930]

37. Cs-1338

38. Db12455

39. Bay-73-6944

40. Bay-73-7388

41. Ncgc00378946-03

42. Ac-33245

43. Hy-14865

44. Ptk 0796, Bay 73-6944

45. D09647

46. E80520

47. Q15426992

48. (4s,4as,5ar,12as)-4,7-bis(dimethylamino)-9-(((2,2-dimethylpropyl)amino)methyl)-3,10,12,12a- Tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide

49. 2-naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-(((2,2- Dimethylpropyl)amino)methyl)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a- Tetrahydroxy-1,11-dioxo-, (4s,4as,5ar,12as)-

2.4 Create Date

2011-12-26

3 Chemical and Physical Properties

Molecular Formula	C₂₉H₄₀N₄O₇
Molecular Weight	556.6 g/mol
XLogP3	3
Hydrogen Bond Donor Count	6
Hydrogen Bond Acceptor Count	10
Rotatable Bond Count	7
Exact Mass	556.28969963 g/mol
Monoisotopic Mass	556.28969963 g/mol
Topological Polar Surface Area	177 Å²
Heavy Atom Count	40
Formal Charge	0
Complexity	1140
Isotope Atom Count	0
Defined Atom Stereocenter Count	4
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Drug and Medication Information

4.1 Drug Indication

Omadacycline is indicated for the treatment of community acquired bacterial pneumonia and acute bacterial skin and skin structure infections caused by omadacycline-susceptible organisms in adults.

FDA Label

Treatment of bacterial pneumonia

Treatment of acute bacterial skin and skin structure infections

5 Pharmacology and Biochemistry

5.1 Pharmacology

Omadacycline can be either bacteriostatic or bacteriocidal depending on the organism involved. It disrupts bacterial protein synthesis without affecting DNA, RNA, or peptidoglycan synthesis. Omadacycline represents an improvement over existing tetracycline agents as it has not been found to be subject to tetracycline resistance mediated by tetracycline efflux pumps encoded by the tet(K), tet(L), and tet(B) or to ribosomal protection proteins encoded by tet(O) and tet(M). Omadacycline is susceptible to RNA mutations which confer resistance to tetracyclines.

5.2 FDA Pharmacological Classification

5.2.1 Active Moiety

OMADACYCLINE

5.2.2 FDA UNII

090IP5RV8F

5.2.3 Pharmacological Classes

Tetracyclines [CS]; Tetracycline-class Antibacterial [EPC]

5.3 ATC Code

J - Antiinfectives for systemic use

J01 - Antibacterials for systemic use

J01A - Tetracyclines

J01AA - Tetracyclines

J01AA15 - Omadacycline

5.4 Absorption, Distribution and Excretion

Absorption

Omadacycline has an mean absolute oral bioavailability of 34.5% and a mean Tmax of2.5 h with oral dosing. With multiple dosing, Omadacycline displays an accumulation factor of 1.5. Official labeling states that food does not significantly impact rate or extent of absorption, however, conflicting data exists suggesting food may lower the bioavailability of omadacycline taken after eating. The exposure in alveolar cells and epithelial lining fluid is 25.8 and 1.5 fold higher than plasma exposure after IV administration, suggesting Omadacycline penetrates the lungs to a significant degree.

Route of Elimination

After IV dosing 27% of Omadacycline was eliminated by the kidneys. In oral dosing 14.4% was found to be eliminated by the kidneys and 81.1% in the feces. Neither renal nor hepatic impairment appears to produce a clinically relevant effect elimination.

Volume of Distribution

Omadacycline has a mean Vd of 256 L after a single dose and a Vss of 190 L.

Clearance

Omadacycline has a mean systemic clearance of 11.24 L/h and a renal clearance of 2.4-3.3 L/h.

5.5 Metabolism/Metabolites

Omadacycline is not known to be metabolized in humans.

5.6 Biological Half-Life

Omadacycline has a mean half life of elimination of 16.2 h.

5.7 Mechanism of Action

Omadacycline binds to the primary tetracycline binding site on the bacterial 30s ribosomal subunit with high specificity. There it acts to block protein synthesis, disrupting many facets of cellular function and resulting in either cell death or stasis.

API SUPPLIERS

01

Transo-Pharm USA LLC

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Medlab Asia & Asia Health

Not Confirmed

TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

Contact Supplier

U.S.A

Virtual Booth

Digital Content

USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT

02

USV Private Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Medlab Asia & Asia Health

Not Confirmed

USV offers custom peptide synthesis ranging from gram to multi-gram to multi-kilogram quantities.

Contact Supplier

India

Virtual Booth

Digital Content

USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT

Portfolio PDF

03

Omgene Life Sciences Pvt. Ltd

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Medlab Asia & Asia Health

Not Confirmed

Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.

Contact Supplier

India

Virtual Booth

Digital Content

USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT

04

Zhejiang Huida Biotech

China

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Medlab Asia & Asia Health

Not Confirmed

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

[{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1641321000,"product":"INTERMEDIATE OF OMADACYCLINE TOSYLATE (4S,4AS,5AR,12AR)-9-(AMINOMETHYL)-4,7-BIS(DIMETHYLAMINO)-1,10,11,12A-TETRAHYDROXY-","address":"SHOP-37, FIRST FLR. KAMLA BHAVAN I I,S. NITYANAND ROAD ANDHERI EAST","city":"MUMBAI,MAHARASHTRA","supplier":"REGEN BIOPHARMA","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"GUFIC BIOSCIENCES","customerCountry":"INDIA","quantity":"3750.00","actualQuantity":"3750","unit":"GMS","unitRateFc":"24","totalValueFC":"93209.5","currency":"USD","unitRateINR":"1851.6","date":"05-Jan-2022","totalValueINR":"6943500","totalValueInUsd":"93209.5","indian_port":"MADRAS AIR","hs_no":"29413090","bill_no":"6960508","productDescription":"Intermediate","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"","customerAddress":"SHOP-37, FIRST FLR. KAMLA BHAVAN I I,S. NITYANAND ROAD ANDHERI EAST"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1663353000,"product":"INTERMEDIATE OF OMADACYCLINE TOSYLATE (4S,4AS,5AR,12AR)-9-(AMINOMETHYL)-4,7-BIS(DIMETHYLAMINO)-1,10,11,12A-TETRAHYDROXY-","address":"SHOP-37, FIRST FLR. KAMLA BHAVAN I I,S. NITYANAND ROAD ANDHERI EAST","city":"MUMBAI,MAHARASHTRA","supplier":"REGEN BIOPHARMA","supplierCountry":"CHINA","foreign_port":"NA","customer":"GUFIC BIOSCIENCES","customerCountry":"INDIA","quantity":"5000.00","actualQuantity":"5000","unit":"GMS","unitRateFc":"19.4","totalValueFC":"97313.4","currency":"USD","unitRateINR":"1559.8","date":"17-Sep-2022","totalValueINR":"7798800","totalValueInUsd":"97313.4","indian_port":"MADRAS AIR","hs_no":"29413090","bill_no":"2485457","productDescription":"Intermediate","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"SHOP-37, FIRST FLR. KAMLA BHAVAN I I,S. NITYANAND ROAD ANDHERI EAST"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1701887400,"product":"OMADACYCLINE TOSYLATE","address":"101, SITARAM MANSION,","city":"KAROL BAGH, NEW DELHI","supplier":"SUZHOU BIOSYNTECH CO LTD","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"JODAS EXPOIM PVT. LTD","customerCountry":"INDIA","quantity":"50.00","actualQuantity":"0.05","unit":"KGS","unitRateFc":"60000","totalValueFC":"3030.9","currency":"USD","unitRateINR":"5046000","date":"07-Dec-2023","totalValueINR":"252300","totalValueInUsd":"3030.9","indian_port":"Hyderabad Air","hs_no":"29413020","bill_no":"9110812","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"ROOM 1812 BUILDING ONE NO.11888 EAST TAIHU AVENUESDNF China","customerAddress":"101, SITARAM MANSION,"}]

Number of Transactions

Total Quantity (GMS)

Total Value (USD)

Quantity (GMS) & Unit rate (USD/GMS) over time

API Imports and Exports

Importing Country	Total Quantity (KGS)	Average Price (USD/KGS)	Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Drugs in Development

01 Axplora

Germany

Medlab Asia & Asia Health

Not Confirmed

Axplora- The partner of choice for complex APIs.

Lead Product(s) : Omadacycline

Therapeutic Area : Infections and Infectious Diseases

Highest Development Status : Approved

Partner/Sponsor/Collaborator : Paratek Pharmaceuticals

Deal Size : Undisclosed

Deal Type : Collaboration

DEALS_DEV

Novasep And Paratek Enhance Collaboration to Manufacture Omadacycline (NUZYRA®), A Novel Tetracyc...

Details : Under the terms of the collaboration, Novasep and Paratek will manufacture NUZYRA® (omadacycline), an FDA-approved tetracycline-class, once-daily oral and intravenous antibiotic for the treatment of adults with CABP and acute bacterial skin and skin str...

Brand Name : Nuzyra

Molecule Type : Small molecule

Upfront Cash : Undisclosed

February 15, 2022

Stock Recap
#PipelineProspector